Literature DB >> 8063696

A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers.

G C Parry1, N Mackman.   

Abstract

NF-kappa B/Rel proteins regulate the inducible expression of many genes in activated monocytes and endothelial cells that contain decameric kappa B and kappa B-like binding sites. In this study, we examined the binding of c-Rel-p65 heterodimers to non-consensus kappa B-like sites from several genes that do not bind prototypic NF-kappa B(p50-p65). c-Rel-p65 heterodimers from both monocytic and endothelial cells bound to the kappa B-like sites in the interleukin-8, granulocyte/macrophage colony-stimulating factor, intercellular adhesion molecule-1, and tissue factor genes but not to a closely related sequence in the granulocyte colony-stimulating factor gene. In contrast, kappa B sites in the endothelial-leukocyte adhesion molecule-1 and Ig kappa genes that match the kappa B consensus, 5'-GGGRNNYYCC-3' (where R indicates A or G, Y indicates C or T, and N indicates any base), bound NF-kappa B(p50-p65). Comparison of the kappa B-like sites indicated that c-Rel-p65 heterodimers bound to a consensus sequence, 5'-HGGARNYYCC-3' (where R indicates A or G, Y indicates C or T, H indicates A, C, or T, and N indicates any base), which differs at position 1 from the kappa B consensus established for binding NF-kappa B(p50-p65) and other members of the NF-kappa B/Rel family. The selective binding of c-Rel-p65 heterodimers to kappa B-like sites in this set of genes may play a central role in regulating inducible gene expression in monocytes and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Lipopolysaccharide induction of gene expression in human monocytic cells.

Authors:  N Mackman
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  [Molecular biology studies of a multicenter phase III study (SIC Study)].

Authors:  T Zimmermann; S Albrecht; G von Gagern
Journal:  Med Klin (Munich)       Date:  1999-10-15

3.  Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.

Authors:  Rong Jiang; Ning-Ping Wang; Kenichi A Tanaka; Jerrold H Levy; Robert A Guyton; Zhi-Qing Zhao; Jakob Vinten-Johansen
Journal:  J Surg Res       Date:  2010-02-23       Impact factor: 2.192

4.  Role of NFkappaB in the mortality of sepsis.

Authors:  H Böhrer; F Qiu; T Zimmermann; Y Zhang; T Jllmer; D Männel; B W Böttiger; D M Stern; R Waldherr; H D Saeger; R Ziegler; A Bierhaus; E Martin; P P Nawroth
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 5.  Role of NF-kappaB in immune and inflammatory responses in the gut.

Authors:  M F Neurath; C Becker; K Barbulescu
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

6.  Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation.

Authors:  L A Sporn; S K Sahni; N B Lerner; V J Marder; D J Silverman; L C Turpin; A L Schwab
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  NF-κB signaling participates in both RANKL- and IL-4-induced macrophage fusion: receptor cross-talk leads to alterations in NF-κB pathways.

Authors:  Minjun Yu; Xiulan Qi; Jose L Moreno; Donna L Farber; Achsah D Keegan
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

8.  MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation.

Authors:  T Yujiri; M Ware; C Widmann; R Oyer; D Russell; E Chan; Y Zaitsu; P Clarke; K Tyler; Y Oka; G R Fanger; P Henson; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation.

Authors:  K S Kilgore; E Schmid; T P Shanley; C M Flory; V Maheswari; N L Tramontini; H Cohen; P A Ward; H P Friedl; J S Warren
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

10.  Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation.

Authors:  J A SoRelle; T Itoh; H Peng; M A Kanak; K Sugimoto; S Matsumoto; M F Levy; M C Lawrence; B Naziruddin
Journal:  Diabetologia       Date:  2013-01-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.